JAMJOOM PHARMACEUTICALS FACTORY TADAWUL:4015:
JAANNOUNCES BOARD RECOMMENDATION TO BUY-BACK ITS SHARES
Jamjoom Pharma Announces Board Recommendation To Buy-Back Its Shares
Jamjoom Pharmaceuticals Factory Co. on 6ix
Earlier from Jamjoom Pharmaceuticals Factory
Later from Jamjoom Pharmaceuticals Factory
- PRESSR: Jamjoom Pharma and the Emirates Dermatology Society join forces to launch “ECZPLORE” – A National Awareness Initiative to help families lead an Eczema-Friendly Life
- Jamjoom Pharma H1 Dividend Per Share SAR 2.00
- PRESSR: New agreement brings breakthrough dyslipidemia treatment to Saudi Arabia and MEA
- Jamjoom Pharma Strikes Strategic Deal With Bio-Thera For Securing Cosentyx Biosimilar In MENA
- SNG: Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA
Follow Jamjoom Pharmaceuticals Factory into a list and get an email when it puts out news.
Follow Jamjoom Pharmaceuticals Factory